Neuraxis Inc (NRXS)
NeurAxis Achieves Critical Milestone; Secures Key Academic Society Guidelines Recommendation for Treatment of Functional Abdominal Pain (FAP) in IBS
NeurAxis Achieves Critical Milestone; Secures Key Academic Society Guidelines Recommendation for Treatment of Functional Abdominal Pain (FAP) in IBS
TruBridge, Inc.: TruBridge Announces Participation in the Truist Securities Healthcare Disruptors & Digital Health Conference
Masimo - New Study Finds Masimo SedLine® Brain Function Monitoring Offers Significant Advantages During Pediatric Anesthesia
Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO® with TULSA-AI® Volume Reduction
CervoMed Announces New Hire to Support Neflamapimod Development and Commercialization
DeepView® System highlighted at the annual British Burn Association conference
Evolus - Evolysse™ Recognized in 2025 Shape Skin Awards
BrainsWay Announces Gold Sponsorship at the 2025 Clinical TMS Society Annual Meeting in San Diego
Quantum-Si’s Single-Molecule Tech Enables Precise, Multiplexed Measurement of Nanobody Binding in a Single Assay
Cytokinetics Announces Call For Proposals For Annual Corporate Giving Program